Review these questions with your healthcare provider: Do you have other medical conditions, including problems with your pancreas or kidneys, or severe problems with your liver, severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems digesting food
95% Confidence Interval [CI], -4.0 to 0.8)
Peptide Therapy Side Effects and Safety Profile: What 2025 Research Shows Common Peptide Therapy Side Effects (Generally Mild): Injection site reactions: redness, swelling, bruising (affects 15-30% of users) Temporary nausea or headaches (first 1-2 weeks) Increased appetite with growth hormone peptides Fluid retention in hands/feet (rare, resolves with dosage adjustment) Fatigue during initial adaptation phase Who Should Avoid Peptide Therapy: Pregnant or breastfeeding women (insufficient safety data) Active cancer patients (growth-promoting peptides may stimulate cell proliferation) Severe kidney or liver disease without medical clearance Anyone without qualified physician supervision FDA Approved vs
Indeed, one study cited by PBM advocates (Kakani et al
Wegovy has some of the same side effects, like headache, nausea, dizziness, and constipation
[] Furthermore, an investigation is required with more extensive clinical evidence to use therapeutically incretin-based medication including tirzepatide in neurological disease